Here are relevant reports on : life-science-reagents-market
-
Inspection Management Software Market by Component (Solution and Services), Deployment Mode, Organization Size, Vertical (Aerospace and Defense, Healthcare and Life Sciences) and Region - Global Forecast to 2026
The inspection management software market is expected to reach USD 13.1 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period. The inspection management software market is dominated by companies such as SAP (Germany), Oracle (US), Siemens (Germany), Dassault Systemes (France), PTC (US), Hexagon (Sweden), Wolters Kluwer (Netherlands), Ideagen (UK), Autodesk (US), Veeva Systems (US), ETQ (US), Gensuite (US), Intelex (Canada), IQS (US), MasterControl (US), MetricStream (US), Penta Technologies (Canada), Pilgrim (US), Plex (US), ReachOutSuite (US), Cority (Canada), ComplianceQuest (US), Omnex Systems (US), Field Eagle (US), MoonVision (Austria), Thrive Technologies (US), Sparta Systems (US), Aras (US), AssurX (US), and Qualityze (US).
- Published: February 2022
- Price: $ 4950
- TOC Available:
-
Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028
The global cardiac marker testing market, valued at US$4.1 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 9.4% from 2023 to 2028, culminating in a forecasted valuation of US$6.9 billion by the end of the period. Increase in chronic heart conditions and aging population, increasing research & funding initiatives from organizations and worldwide rise in prevalence of cardiovascular diseases are a few drivers that collectively contribute to the growth of this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Oligonucleotide Synthesis Market by Product {Drugs [ASO, siRNA], Synthesized Oligos [Product (Primers, Probes), Type (Custom, Predesigned)], Reagents, Equipment}, Application (Therapeutic, Research, Diagnostics) - Forecast to 2030
The Asia Pacific Oligonucleotide Synthesis market, valued at USD 1.76 billion in 2024, stood at USD 2.08 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2025 to 2030, culminating in a forecasted valuation of USD 4.88 billion by the end of the period. This expansion is driven by increasing demand from therapeutics, diagnostics, and research.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030
Global HIV diagnostics market valued at $2.96B in 2024, reached $3.25B in 2025, and is projected to grow at a robust 10.3% CAGR, hitting $ 5.31B by 2030. The HIV diagnostics market is driven by several key factors, such as the rising prevalence of HIV/AIDS, the increasing number of blood transfusions and blood donations, advantages offered by POC diagnostic kits & instruments, and the growing focus on initiatives for HIV awareness.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
North America Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
The North America Nucleic Acid Isolation and Purification Market, valued at USD 2.80 billion in 2024, stood at USD 2.98 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of USD 4.64 billion by the end of the period. The growth of the North America nucleic acid isolation and purification market is largely dependent on the region's substantial number of molecular tests and quick acceptance of NGS-based workflows.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Chatbot Market by Offering, Bot Communication (Text, Audio, & Video), Type, Business Function (Sales & Marketing, Contact Centers), Channel Integration, Vertical (Retail & eCommerce, Healthcare & Life Sciences) and Region - Global Forecast to 2028
The market for chatbot market size is projected to reach USD 15.5 billion by 2028, at a CAGR of 23.3% during the forecast period. The chatbot market vendors have implemented various types of organic and inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. Key players operating in the chatbot market include Google (US), Microsoft (US), IBM (US), AWS (US), Baidu (China), Oracle (US), SAP (Germany), OpenAI (US), Salesforce (US), Meta (US), Artificial Solutions (Sweden), ServiceNow (US), [24]7.ai (US), Kore.ai (US), Conversica (US), Inbenta (US), Creative Virtual (US), Avaamo (US), Haptik (India), Solvvy (US), Gupshup (US), Aivo (US), Personetics (US), LivePerson (US), Freshworks (India), Engati (US), Botsify (Pakistan), Yellow.ai (US), Drift (US), Intercom (US), Chatfuel (US), Landbot (Spain), Pandorabots (US), Customers.ai (US), Rasa (Germany), and BotsCrew (UK).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Insights-as-a-Service Market by Application (Revenue Cycle Management, Governance, Risk & Compliance, Customer Life Cycle Management), Type, Deployment Model, Organization Size, Vertical, and Region - Global Forecast to 2021
The Insights-as-a-Service market size is expected to grow from USD 1.16 Billion in 2016 to USD 3.33 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 23.5% during the forecast period. The major drivers of this market include the need for improved customer satisfaction and operational performance.
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
North America Oligonucleotide Synthesis Market by Product [(Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type (Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics)] - Forecast to 2030
The North America Oligonucleotide Synthesis market, valued at USD4.02 billion in 2024, stood at USD4.77 billion in 2025 and is projected to advance at a resilient CAGR of 18.9% from 2025 to 2030, culminating in a forecasted valuation of USD11.34 billion by the end of the period. The market is growing due to the strong demand from therapeutics, diagnostics and research. Pharma and biotech end users require high-purity DNA/RNA oligos for siRNA, antisense, aptamers and guide RNAs for gene editing.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
